Nucana plc
SEC CIK 1709626 · NCNA · last insider filing 2026-06-24
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Levy Elliott M. | Director | filed 2026 - 2026 |
| Mellish Martin C.B. | Director | filed 2026 - 2026 |
| Griffith Hugh | Director · Chief Executive Officer | filed 2026 - 2026 |
| Kay Andrew Martin | Director | filed 2026 - 2026 |
| Leperlier Cyrille | Director | filed 2026 - 2026 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Bloss Jeffrey D. | Chief Medical Officer | filed 2026 - 2026 |
| Bruce Theresa Margaret Ms | Chief Operating Officer | filed 2026 - 2026 |
| Harrison David James | Head of Translational Medicine | filed 2026 - 2026 |
| Webster Ian Alexander | See Remarks | filed 2026 - 2026 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.